Protein engineering of DAB-IL-2 fusion toxins to increase biologic potency.
Kiyokawa
T
T
Evans Department of Clinical Research, Boston University Medical Center, Massachusetts 02118.
Williams
D P
DP
Snider
C E
CE
Waters
C A
CA
Nichols
J C
JC
Strom
T B
TB
Murphy
J R
JR
D000595:Amino Acid Sequence; D000818:Animals; D004167:Diphtheria Toxin / Q000235:genetics / Q000494:pharmacology*; D006801:Humans; D007376:Interleukin-2 / Q000235:genetics / Q000494:pharmacology*; D008969:Molecular Sequence Data; D011993:Recombinant Fusion Proteins / Q000494:pharmacology*
C054780:DAB(486)-interleukin 2; D004167:Diphtheria Toxin; D007376:Interleukin-2; D011993:Recombinant Fusion Proteins